Egyptian Liver Journal

Table 1 Baseline characteristics in both groups

From: Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis

			Range	Mean ± S.D	t test	p-value
Age		Group I	33–63	47.48 ± 7.36	0.030	0.863
Age		Group II	33–65	47.75 ± 6.82
Sex			Group I	Group II	Total
Male		N	22	30	52
Male		%	55.0%	75.0%	65.0%
Female		N	18	10	28
Female		%	45.0%	25.0%	35.0%
Total		N	40	40	80
Total		%	100.0%	100.0%	100.0%
Chi-square	X²	3.516
Chi-square	p-value	0.0610.061

Back to article page